Project Grant R01DK141366
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,778,953 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Minnesota. The award, with a start date of September 16, 2025 and a completion date of June 30, 2029, will support research on the dynamics of the HIV reservoir and its association with metabolic complications of HIV infection in individuals receiving...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $200,660 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Albert Einstein College of Medicine. The grant will fund the development and testing of a mobile health application for a digital mind-body intervention (DMBI) targeted at improving psychological distress and quality-of-life among Black and Hispanic patients with inflammatory bowel disease...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $847,498 to New York University (NYU) to develop and test an AI-driven clinical decision support system (CDS) and chatbot for managing patients on incretin mimetic medications (IMMs) for obesity treatment. The goal is to increase patient adherence and reduce the burden on healthcare...
- This federal Project Grant award of $158,943, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), will support a pilot intervention to address the comorbidity of type 2 diabetes (T2D) and depression among South Asian patients in New York City. The grantee, New York University (NYU) Grossman School of Medicine, will adapt their existing community health worker (CHW)-led T2D intervention to...
- This $780,853 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) aims to investigate the impact of a glucagon-like peptide-1 receptor agonist on simian immunodeficiency virus (SIV)/human immunodeficiency virus (HIV) pathogenesis and antiretroviral therapy (ART) administration in people living with HIV. The project, to be conducted by the University of Pittsburgh from April 2025 through March 2030, will assess changes in T-cell and...
- This $941,418 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to assess the feasibility of a virtual reality-enhanced Mindfulness-Based Stress Reduction (MBSR-VR) intervention to reduce stress among emerging adults (16-20 years old) with type 1 diabetes. The project will adapt the MBSR program for virtual delivery, collaborate with a youth community advisory board,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This federal Project Grant award of $768,260.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is funding a project titled "Improving the Treatment of Depression among Youth with HIV" at Rhode Island Hospital, a division of Lifespan Corporation. The goal of the project is to train clinicians in a tailored, measured-care approach combining cognitive behavioral therapy and medication management to effectively reduce...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $769,155 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan to conduct a two-arm, hybrid type 1 effectiveness-implementation trial. The objective is to compare an adapted diabetes self-management support (DSMS) intervention delivered virtually against enhanced usual care for adults with type 2 diabetes and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $3,096,280.00 to conduct research on the effects of internet-based cognitive behavioral therapy for depression (ICBT-D) in people with HIV (PWH). The key objectives are to: 1) Determine the effects of ICBT-D on insulin resistance in depressed PWH on antiretroviral therapy; 2) Examine the effects of ICBT-D on monocyte activation and markers of gut barrier integrity in this population; and 3) Analyze metabolomic profiles to identify novel mechanisms linking successful depression treatment to improved insulin resistance. The project will be conducted by the Trustees of Indiana University over the period from September 1, 2025 to August 31, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.1m | 8/27/25 |